A versatile theranostic magnetic polydopamine iron oxide NIR laser-responsive nanosystem containing doxorubicin for chemo-photothermal therapy of melanoma.

Combination therapy Doxorubicin NIR-sensitive drug release Theranostic nanoparticles

Journal

Biomaterials advances
ISSN: 2772-9508
Titre abrégé: Biomater Adv
Pays: Netherlands
ID NLM: 9918383886206676

Informations de publication

Date de publication:
12 Feb 2024
Historique:
received: 21 11 2023
revised: 06 02 2024
accepted: 07 02 2024
medline: 19 2 2024
pubmed: 19 2 2024
entrez: 18 2 2024
Statut: aheadofprint

Résumé

Theranostics nanoparticles (NPs) have recently received much attention in cancer imaging and treatment. This study aimed to develop a multifunctional nanosystem for the targeted delivery of photothermal and chemotherapy agents. Fe

Identifiants

DOI: 10.1016/j.bioadv.2024.213797 PMID: 38368693
pubmed: 38368693
pii: S2772-9508(24)00040-2
doi: 10.1016/j.bioadv.2024.213797
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213797

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mahvash Dehghankhold (M)

Department of Pharmaceutical Nanotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Student Research committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Fatemeh Ahmadi (F)

Research Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pharmaceutics, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Navid Nezafat (N)

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Mehdi Abedi (M)

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Pooya Iranpour (P)

Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Amirreza Dehghanian (A)

Molecular Pathology and Cytogenetics Division, Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.

Omid Koohi-Hosseinabadi (O)

Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran.

Amin Reza Akbarizadeh (AR)

Drug and Food Control Department, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Zahra Sobhani (Z)

Research Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Iran; Drug and Food Control Department, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: sobhani@sums.ac.ir.

Classifications MeSH